不孕女性子宫和卵巢的基线解剖评估:关于哪种评估方法在改善生育结局方面最安全有效的系统综述
本系统综述由世界卫生组织倡议开展,评估不孕女性子宫和卵巢解剖的初始检查方法。共纳入19项研究进行叙述性合成,多数诊断相关证据质量低或极低。推荐对有盆腔病理症状或体征者行经阴道超声,有指征时行宫腔镜,但不建议常规行宫腔镜或子宫输卵管造影作为治疗手段。
要点
- 对有盆腔解剖病理症状或体征的不孕女性,应提供经阴道超声检查。
- 无盆腔病理症状者不应常规行经阴道超声;超声正常者不应常规行宫腔镜。
- 子宫输卵管造影不应作为治疗性操作,不改善期待管理下的临床妊娠率。
核心结论
- 本综述为不孕女性初始解剖评估提供现有最可靠证据,以助全球临床医生选择最有用的检查并避免不必要的负担。
- 多数诊断相关发现基于低或极低质量证据(GRADE)。
研究设计与样本
- 系统综述,检索截至2016年6月6日,无日期或语言限制,共检索到3968篇文献,最终纳入19项研究。
- 采用叙述性合成,并按文章类型使用相应工具评估偏倚风险。
- 2015年10月在日内瓦召开共识专家咨询会讨论数据并形成最佳实践共识,2016年进行独立专家评审。
主要发现
- 对有不孕女性盆腔病理症状或体征者应提供经阴道超声,无盆腔病理症状者不应常规提供。
- 超声怀疑宫内病变时应提供宫腔镜;超声正常的不孕女性不应常规提供宫腔镜;超声正常且行IVF者,宫腔镜不改善结局。
- 子宫输卵管造影在不孕女性中不改善期待管理下异性伴侣的临床妊娠率,不应作为治疗性操作提供。
- 良好实践要点建议生育照护提供者应确认所有不孕女性近期接受过盆腔检查、宫颈筛查及符合当地指南的健康女性筛查。
关键数值与推荐
- 推荐强度照原文:应提供经阴道超声(有症状或体征者);不应常规提供经阴道超声(无症状者)。
- 应提供宫腔镜(超声怀疑宫内病变时);不应常规提供宫腔镜(超声正常者);IVF且超声正常者宫腔镜不改善结局。
- 子宫输卵管造影不应作为治疗性操作提供。
- 良好实践要点:确认近期盆腔检查、宫颈筛查和健康女性筛查。
临床怎么用
- 对有盆腔病理症状或体征的不孕女性提供经阴道超声评估解剖。
- 无盆腔病理症状者不常规行经阴道超声,超声正常者不常规行宫腔镜。
- 子宫输卵管造影不作为治疗性操作用于改善妊娠结局。
- 生育照护者应确认患者近期盆腔检查、宫颈筛查及健康女性筛查符合当地指南。
局限性
- 多数诊断相关发现基于低或极低质量证据(GRADE);低质量提示进一步研究很可能对效应估计的置信度产生重要影响并可能改变估计,极低质量提示任何效应估计非常不确定。
- 作者指出需进一步研究以降低不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This review focuses on the initial presentation of women who suspect that they are infertile, and how best to assess the anatomy of their uterus and ovaries in order to investigate the cause of their infertility, and potentially improve desired fertility outcomes. This review was undertaken as part of a World Health Organization initiative to assess the evidence available to address guidance for the diagnosis and treatment of infertility within a global context. Providing access to care for infertile women will help to ease the psycho-social burdens, such as ostracization, intimate partner violence and other negative consequences of being involuntarily childless or unable to become pregnant despite desiring a biological child or children. OBJECTIVE AND RATIONALE: The aim of this paper was to present an evidence base for the diagnostic and prognostic value of various investigations used for detecting uterine and/or ovarian pathology in women presenting at fertility clinics for their initial assessment. SEARCH METHODS: We performed a comprehensive search of relevant studies on 28 August and 10 September 2014. A further search was performed on 6 June 2016 to ensure all possible studies were captured. These strategies were not limited by date or language. The search returned 3968 publications in total; 63 full text articles were retrieved and 10 additional studies were found through hand-searching. After excluding 54, a total of 19 studies were analysed. We extracted and tabulated data on the characteristics, quality and results of each eligible study and combined the findings in a narrative synthesis. Risk of bias was assessed according to article type using tools such as assessment of the methodological quality of systematic reviews, Newcastle Ottawa Scale, Cochrane risk of bias tool, quality assessment tool for diagnostic accuracy studies and quality in prognostic studies. Nineteen studies were selected as being the best evidence available. A narrative synthesis of the data was undertaken. Discussion of the data, and resultant consensus for best practice were accomplished in a consensus expert consultation in Geneva, October 2015. An independent expert review process concerning this work and outcomes was conducted during 2016. OUTCOMES: The draft recommendations presented here apply to infertile women whether or not they are undergoing fertility treatment. Transvaginal ultrasound (TVUS) should be offered to all infertile women with symptoms or signs of anatomic pelvic pathology. TVUS should not be offered routinely to women without symptoms of pelvic pathology. Hysteroscopy should be offered if intrauterine pathology is suspected by TVUS. Hysteroscopy should not be routinely offered to infertile women who have normal TVUS findings. In women who have normal TVUS findings and are undergoing IVF, hysteroscopy does not improve the outcome. Good practice points recommend that providers of fertility care should confirm that all infertile women have a recent pelvic examination, recent cervical screening and well-woman screening in line with local guidelines. Additionally, hystero-contrast salpingography in infertile women does not improve clinical pregnancy rates with expectant management in heterosexual couples and should not be offered as a therapeutic procedure. Most of the findings of this review on diagnosis are based on a low, or very low, quality of evidence, according to GRADE Working Group (grading of recommendations, assessment, development and evaluation) criteria. A low quality grading indicates that further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate, while a very low grade indicates that any estimate of effect is very uncertain. WIDER IMPLICATIONS: This review provides the most reliable evidence available to guide clinicians worldwide in the initial, evidence-based investigation of women with fertility problems in order to undertake the most useful investigation and avoid the burden of unnecessary tests.
引用
- Armstrong SC, Showell M, Stewart EA, et al. Baseline anatomical assessment of the uterus and ovaries in infertile women: a systematic review of the evidence on which assessment methods are the safest and most effective in terms of improving fertility outcomes. Hum Reprod Update. 2017. PMID: 28903473. doi:10.1093/humupd/dmx019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。